Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, Canada.
McGill International TB Centre, Montreal, Canada.
PLoS Negl Trop Dis. 2021 Dec 8;15(12):e0010029. doi: 10.1371/journal.pntd.0010029. eCollection 2021 Dec.
Leprosy is the second most prevalent mycobacterial disease globally. Despite the existence of an effective therapy, leprosy incidence has consistently remained above 200,000 cases per year since 2010. Numerous host genetic factors have been identified for leprosy that contribute to the persistently high case numbers. In the past decade, genetic epidemiology approaches, including genome-wide association studies (GWAS), identified more than 30 loci contributing to leprosy susceptibility. However, GWAS loci commonly encompass multiple genes, which poses a challenge to define causal candidates for each locus. To address this problem, we hypothesized that genes contributing to leprosy susceptibility differ in their frequencies of rare protein-altering variants between cases and controls. Using deep resequencing we assessed protein-coding variants for 34 genes located in GWAS or linkage loci in 555 Vietnamese leprosy cases and 500 healthy controls. We observed 234 nonsynonymous mutations in the targeted genes. A significant depletion of protein-altering variants was detected for the IL18R1 and BCL10 genes in leprosy cases. The IL18R1 gene is clustered with IL18RAP and IL1RL1 in the leprosy GWAS locus on chromosome 2q12.1. Moreover, in a recent GWAS we identified an HLA-independent signal of association with leprosy on chromosome 6p21. Here, we report amino acid changes in the CDSN and PSORS1C2 genes depleted in leprosy cases, indicating them as candidate genes in the chromosome 6p21 locus. Our results show that deep resequencing can identify leprosy candidate susceptibility genes that had been missed by classic linkage and association approaches.
麻风病是全球第二大常见的分枝杆菌病。尽管有有效的治疗方法,但自 2010 年以来,麻风病的发病率一直保持在每年 20 万例以上。已经确定了许多宿主遗传因素导致麻风病,这些因素导致病例数量持续居高不下。在过去的十年中,遗传流行病学方法,包括全基因组关联研究(GWAS),已经确定了 30 多个与麻风病易感性相关的位点。然而,GWAS 位点通常包含多个基因,这给每个位点确定因果候选基因带来了挑战。为了解决这个问题,我们假设导致麻风病易感性的基因在病例和对照之间的罕见蛋白改变变体的频率上有所不同。我们使用深度重测序评估了位于 GWAS 或连锁位点的 34 个基因中的蛋白质编码变异,这些基因位于 555 名越南麻风病患者和 500 名健康对照者中。我们在目标基因中观察到 234 个非同义突变。在麻风病病例中,IL18R1 和 BCL10 基因的蛋白改变变体显著减少。IL18R1 基因与 IL18RAP 和 IL1RL1 一起位于染色体 2q12.1 上的麻风病 GWAS 位点。此外,在最近的 GWAS 中,我们发现了一个与染色体 6p21 上麻风病相关的 HLA 独立信号。在这里,我们报告了在麻风病病例中缺失的 CDSN 和 PSORS1C2 基因的 CDS 中的氨基酸变化,表明它们是染色体 6p21 位点的候选基因。我们的结果表明,深度重测序可以识别经典连锁和关联方法错过的麻风病候选易感基因。